Cortical spreading depression as a target for anti-migraine agents

Journal of Headache and Pain

Volumn 14, Issue 1, 2013, Pages 1-18

  Costa, Cinzia ^a,c   Tozzi, Alessandro ^a,c   Rainero, Innocenzo ^b   Cupini, Letizia Maria ^e   Calabresi, Paolo ^a,c   Ayata, Cenk ^d   Sarchielli, Paola ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e S EUGENIO HOSPITAL   (Italy)

Author keywords

Antiepileptics; Calcitonin gene related peptides; Calcium channels; Cortical spreading depression; Current prophylactic drugs; Gepants; Glutamate; Ionotropic glutamate receptors; Sodium channels; Tonabersat

Indexed keywords

ANTIMIGRAINE AGENT; STEROID; ANALGESIC AGENT;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; EXPERIMENTAL MODEL; GAP JUNCTION; HEADACHE; HEREDITY; HUMAN; MEMBRANE PERMEABILITY; MIGRAINE AURA; NEUROIMAGING; NONHUMAN; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROPHYLAXIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPREADING CORTICAL DEPRESSION; SYNAPTIC TRANSMISSION; DRUG EFFECTS; MIGRAINE DISORDERS;

ANALGESICS; CORTICAL SPREADING DEPRESSION; HUMANS; MIGRAINE DISORDERS;

EID: 84895437660     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1186/1129-2377-14-62     Document Type: Article

References (206)

1. Somjen GG (2005) Aristides Leão's discovery of cortical spreading depression. J Neurophysiol 94:2-4
2. Fabricius M, Fuhr S, Bhatia R, Boutelle M, Hashemi P, Strong AJ, Lauritzen M (2006) Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 129:778-790
3. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ (2011) Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 31:17-35
4. Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439-447
5. Somjen GG (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 81:1065-1096
6. Strong AJ, Dardis R (2005) Depolarisation phenomena in traumatic and ischaemic brain injury. In: Pickard JD (ed) Advances and Technical Standards in Neurosurgery, Springer, Wien, vol 30, Austria vol. pp 3-49
7. Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622-625
8. Tfelt-Hansen PC (2010) History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia 30:780-792
9. Sánchez del Rio M, Alvarez Linera J (2004) Functional neuroimaging of headaches. Lancet Neurol 3:645-651
10. Smith JM, Bradley DP, James MF, Huang CL (2006) Physiological studies of cortical spreading depression. Biol Rev Camb Philos Soc 81:457-481
11. Smith JM, James MF, Fraser JA, Huang CL (2008) Translational imaging studies of cortical spreading depression in experimental models for migraine aura. Expert Rev Neurother 8:759-768
12. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 30:8807-8814
13. Hansen JM (2010) Familial hemiplegic migraine. Dan Med Bull 57:B4183
14. Bolay H, Berman NE, Akcali D (2011) Sex-related differences in animal models of migraine headache. Headache 51:891-904
15. Eikermann-Haerter K, Kudo C, Moskowitz MA (2007) Cortical spreading depression and estrogen. Headache 47(Suppl 2):S79-S85
16. Eikermann-Haerter K, Ayata C (2010) Cortical spreading depression and migraine. Curr Neurol Neurosci Rep 10:167-173
17. Eikermann-Haerter K, Can A, Ayata C (2012) Pharmacological targeting of spreading depression in migraine. Expert Rev Neurother 12:297-306
18. Merikangas KR (2013) Contributions of epidemiology to our understanding of migraine. Headache 53:230-246
19. Headache Classification Committee of The International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(1):1-160
20. Montagna P (2008) Migraine genetics. Expert Rev Neurother 8:1321-1330
21. Pietrobon D (2007) Familial hemiplegic migraine. Neurotherapeutics 4:274-284
22. Lashley KS (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 46:331-339
23. Leão AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390
24. Leão AAP (1944) Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 7:391-396
25. Leão AAP (1947) Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol 10:409-414
26. Wolff HG (1948) Headache mechanisms. Bull U S Army Med Dep 8:641-653
27. Olesen J, Larsen B, Lauritzen M (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9:344-352
28. Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117:199-210
29. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen NA, Andersen AR, Karle A (1990) Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28:791-798
30. Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Sanchez del Rio M, Lee EJ, Rosen BR, Moskowitz MA (1998) Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 43:25-31
31. Cutrer FM, O'Donnell A, Sanchez del Rio M (2000) Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurology 55(Suppl 2):S36-S45
32. Cao Y, Welch KM, Aurora S, Vikingstad EM (1999) Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 56:548-554
33. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98:4687-4692
34. Oberndorfer S, Wöber C, Nasel C, Asenbaum S, Lahrmann H, Fueger B, Grisold W (2004) Familial hemiplegic migraine: follow-up findings of diffusion-weighted magnetic resonance imaging (MRI), perfusion-MRI and [99mTc] HMPAO-SPECT in a patient with prolonged hemiplegic aura. Cephalalgia 24:533-539
35. Jäger HR, Giffin NJ, Goadsby PJ (2005) Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 25:323-332
36. Belvís R, Ramos R, Villa C, Segura C, Pagonabarraga J, Ormazabal I, Kulisevsky J (2010) Brain apparent water diffusion coefficient magnetic resonance image during a prolonged visual aura. Headache 50:1045-1049
37. Mourand I, Menjot de Champfleur N, Carra-Dallière C, Le Bars E, Roubertie A, Bonafé A, Thouvenot E (2012) Perfusion-weighted MR imaging in persistent hemiplegic migraine. Neuroradiology 54:255-260
38. Bereczki D, Kollár J, Kozák N, Viszokay K, Barta Z, Sikula J, Magyar MT (2008) Cortical spreading edema in persistent visual migraine aura. Headache 48:1226-1229
39. Smith M, Cros D, Sheen V (2002) Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 58:1308-1310
40. Arnold G, Reuter U, Kinze S, Wolf T, Einhäupl KM (1998) MWA shows gadolinium enhancement which is reversed following prophylactic treatment. Cephalalgia 18:644-646
41. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM (2001) Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 50:582-587
42. Hall SD, Barnes GR, Hillebrand A, Furlong PL, Singh KD, Holliday IE (2004) Spatio-temporal imaging of cortical desynchronization in migraine visual aura: a magnetoencephalography case study. Headache 44:204-208
43. Grafstein B (1956) Mechanism of spreading cortical depression. J Neurophysiol 19:154-171
44. Strong AJ (2005) Dr. Bernice Grafstein's paper on the mechanism of spreading depression. J Neurophysiol 94:5-7
45. Martins-Ferreira H, Nedergaard M, Nicholson C (2000) Perspectives on spreading depression. Brain Res Brain Res Rev 32:215-234
46. de Azeredo FA (1991) Transient changes in energy metabolites and intracellular pH during spreading depression in the chick retina. Metab Brain Dis 6:75-82
47. Gault LM, Lin CW, LaManna JC, Lust WD (1994) Changes in energy metabolites, cGMP and intracellular pH during cortical spreading depression. Brain Res 641:176-180
48. Footitt DR, Newberry NR (1998) Cortical spreading depression induces an LTP-like effect in rat neocortex in vitro. Brain Res 781:339-342
49. Világi I, Klapka N, Luhmann HJ (2001) Optical recording of spreading depression in rat neocortical slices. Brain Res 898:288-296
50. Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF (2007) Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. J Pharmacol Exp Ther 321:564-572
51. Petzold GC, Haack S, von Bohlen Und Halbach O, Priller J, Lehmann TN, Heinemann U, Dirnagl U, Dreier JP (2008) Nitric oxide modulates spreading depolarization threshold in the human and rodent cortex. Stroke 39:1292-1299
52. McLachlan RS (1992) Suppression of spreading depression of Leao in neocortex by an N-methyl-D-aspartate receptor antagonist. Can J Neurol Sci 19:487-491
53. Obrenovitch TP, Zilkha E (1996) Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-Daspartate receptor complex. Br J Pharmacol 117:931-937
54. Jing APG, Somjen GG (1993) Role of calcium channels in spreading depression in rat hippocampal slices. Brain Res 604:251-259
55. Footitt DR, Newberry NR (1998) Cortical spreading depression induces an LTP-like effect in rat neocortex in vitro. Brain 781:339-342
56. Hernándéz-Cáceres J, Macias-González R, Brozek G, Bures J (1987) Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats. Brain Res 437:360-364
57. Marrannes R, Willems R, De Prins E, Wauquier A (1988) Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res 457:226-240
58. Lauritzen M, Hansen AJ (1992) The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab 12:223-229
59. Nellgård B, Wieloch T (1992) NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand 146:497-503
60. Gorji A, Scheller D, Straub H, Tegtmeier F, Köhling R, Höhling JM, Tuxhorn I, Ebner A, Wolf P, Werner Panneck H, Oppel F, Speckmann EJ (2001) Spreading depression in human neocortical slices. Brain Res 906:74-83
61. Berger M, Speckmann EJ, Pape HC, Gorji A (2008) Spreading depression enhances human neocortical excitability in vitro. Cephalalgia 28:558-562
62. Tottene A, Urbani A, Pietrobon D (2011) Role of different voltage-gated Ca2 + channels in cortical spreading depression: specific requirement of P/Qtype Ca2+ channels. Channels (Austin) 5:110-114
63. Petzold GC, Scheibe F, Braun JS, Freyer D, Priller J, Dirnagl U, Dreier JP (2005) Nitric oxide modulates calcium entry through P/Q-type calcium channels and N-methyl-d-aspartate receptors in rat cortical neurons. Brain Res 1063:9-14
64. Zhou N, Gordon GR, Feighan D, MacVicar BA (2010) Transient swelling, acidification, and mitochondrial depolarization occurs in neurons but not astrocytes during spreading depression. Cereb Cortex 20:2614-2624
65. Herreras O, Somjen GG (1993) Analysis of potential shifts associated with recurrent spreading depression and prolonged unstable SD induced by microdyalisis of elevated K+ in hippocampus of anesthetized rats. Brain Res 610:283-294
66. Richter F, Ebersberger A, Schaible HG (2002) Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci Lett 334:123-126
67. Sugaya E, Takato M, Noda Y (1975) Neuronal and glial activity during spreading depression in cerebral cortex of cat. J Neurophysiol 38(4):822-841
68. Tuckwell HC, Hermansen CL (1981) Ion and transmitter movements during spreading cortical depression. Int J Neurosci 12:109-135
69. Somjen GG, Aitken PG (1984) The ionic and metabolic responses associated with neuronal depression of Leão's type in cerebral cortex and in hippocampal formation. An Acad Bras Cienc 56(4):495-504
70. Tozzi A, de Iure A, Di Filippo M, Costa C, Caproni S, Pisani A, Bonsi P, Picconi B, Cupini LM, Materazzi S, Geppetti P, Sarchielli P, Calabresi P (2012) Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc Natl Acad Sci USA 109:18985-18990
71. Akerman S, Holland PR, Goadsby PJ (2008) Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockade. Brain Res 1229:27-36
72. Addae JI, Evans SM, Ali N, Stone TW (2000) NMDA-induced changes in a cortical network in vivo are prevented by AMPA. Brain Res 869:211-215
73. Anderson TR, Andrew RD (2002) Spreading depression: imaging and blockade in the rat neocortical brain slice. J Neurophysiol 88:2713-2725
74. Addae JI, Ali N, Stone TW (2011) Effects of AMPA and clomethiazole on spreading depression cycles in the rat neocortex in vivo. Eur J Pharmacol 653:41-46
75. Holland PR, Akerman S, Goadsby PJ (2010) Cortical spreading depressionassociated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia 30:519-527
76. Haghir H, Kovac S, Speckmann EJ, Zilles K, Gorji A (2009) Patterns of neurotransmitter receptor distributions following cortical spreading depression. Neuroscience 163:1340-1352
77. Van Harreveld A, Ochs S (1957) Electrical and vascular concomitants of spreading depression. Am J Physiol 189:159-166
78. Wahl M, Lauritzen M, Schilling L (1987) Change of cerebrovascular reactivity after cortical spreading depression in cats and rats. Brain Res 411:72-80
79. Fabricius M, Akgoren N, Lauritzen M (1995) Arginine-nitric oxide pathway and cerebrovascular regulation in cortical spreading depression. Am J Physiol 269:H23-H29
80. Duckrow RB (1991) Regional cerebral blood flow during spreading cortical depression in conscious rats. J Cereb Blood Flow Metab 11:150-154
81. Duckrow RB (1993) A brief hypoperfusion precedes spreading depression if nitric oxide synthesis is inhibited. Brain Res 618:190-195
82. Piper RD, Lambert GA, Duckworth JW (1991) Cortical blood flow changes during spreading depression in cats. Am J Physiol 261:H96-H102
83. Lauritzen M, Jørgensen MB, Diemer NH, Gjedde A, Hansen AJ (1982) Persistent oligemia of rat cerebral cortex in the wake of spreading depression. Ann Neurol 12:469-474
84. Goadsby PJ (1992) The oligemic phase of cortical spreading depression is not blocked by tirilazad mesylate (U-74006F). Brain Res 588:140-143
85. Ba AM, Guiou M, Pouratian N, Muthialu A, Rex DE, Cannestra AF, Chen JW, Toga AW (2002) Multiwavelength optical intrinsic signal imaging of cortical spreading depression. J Neurophysiol 88:2726-2735
86. Guiou M, Sheth S, Nemoto M, Walker M, Pouratian N, Ba A, Toga AW (2005) Cortical spreading depression produces long-term disruption of activityrelated changes in cerebral blood volume and neurovascular coupling. J Biomed Opt 10(1):11004
87. O'Farrell AM, Rex DE, Muthialu A, Pouratian N, Wong GK, Cannestra AF, Chen JW, Toga AW (2000) Characterization of optical intrinsic signals and blood volume during cortical spreading depression. Neuroreport 11:2121-2125
88. Ayata C, Shin HK, Salomone S, Ozdemir-Gursoy Y, Boas DA, Dunn AK, Moskowitz MA (2004) Pronounced hypoperfusion during spreading depression in mouse cortex. J Cereb Blood Flow Metab 24:1172-1182
89. Brennan KC, Beltrán-Parrazal L, López-Valdés HE, Theriot J, Toga AW, Charles AC (2007) Distinct vascular conduction with cortical spreading depression. J Neurophysiol 97:4143-4151
90. Chang JC, Shook LL, Biag J, Nguyen EN, Toga AW, Charles AC, Brennan KC (2010) Biphasic direct current shift, haemoglobin desaturation and neurovascular uncoupling in cortical spreading depression. Brain 133:996-1012
91. Wang M, Obrenovich TP, Ureniak J (2003) Effects of the nitric oxide donor, DEA/NO on cortical spreading depression. Neuropharmacology 44:949-957
92. Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP (2004) ET-1 induces cortical spreading depression via activation of the ETA receptor/ phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol 286: H1339-H1346
93. Dreier JP, Kleeberg J, Alam M, Major S, Kohl-Bareis M, Petzold GC, Victorov I, Dirnagl U, Obrenovitch TP, Priller J (2007) Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Exp Biol Med (Maywood) 232:204-213
94. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543-552
95. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, van de Ven RC, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41:701-710
96. Pietrobon D (2005) Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol 15:257-265
97. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM (2009) Migraine and genetic and acquired vasculopathies. Cephalalgia 29:1006-1017
98. Uchitel OD, Inchauspe CG, Urbano FJ, Di Guilmi MN (2012) CaV2.1 voltage activated calcium channels and synaptic transmission in familial hemiplegic migraine pathogenesis. J Physiol Paris 106:12-22
99. Inchauspe CG, Urbano FJ, Di Guilmi MN, Forsythe ID, Ferrari MD, van den Maagdenberg AM, Uchitel OD (2010) Gain of function in FHM-1 Cav 2.1 knock-in mice is related to the shape of the action potential. J Neurophysiol 104:291-299
100. Pietrobon D (2010) Cav2.1 channelopathies. Pflugers Arch 460:375-393
101. Pietrobon D (2010) Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J Physiol 588:1871-1878
102. Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, Pietrobon D (2002) Familial hemiplegic migraine mutations increase Ca2+ influx through single human Cav2.1 channels and decrease maximal Cav2.1 current density in neurons. Proc Natl Acad Sci USA 99:13284-13289
103. Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, van den Maagdenberg AM, Ferrari MD, Pietrobon D (2009) Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 61(5):762-773
104. van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, Barrett CF, Gherardini L, van de Ven RC, Todorov B, Broos LA, Tottene A, Gao Z, Fodor M, De Zeeuw CI, Frants RR, Plesnila N, Plomp JJ, Pietrobon D, Ferrari MD (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Cav2.1 S218L mice. Ann Neurol 67:85-98
105. Ayata C, Shimizu-Sasamata M, Lo EH, Noebels JL, Moskowitz MA (2000) Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the α1A subunit of P/Q type calcium channels. Neuroscience 95:639-645
106. Leo L, Gherardini L, Barone V, De Fusco M, Pietrobon D, Pizzorusso T, Casari G (2011) Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 7(6):e1002129
107. Eikermann-Haerter K, Yuzawa I, Dilekoz E, Joutel A, Moskowitz MA, Ayata C (2011) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol 69:413-418
108. Nagel-Leiby S, Welch KM, Grunfeld S, D’Andrea G (1990) Ovarian steroid levels in migraine with and without aura. Cephalalgia 10:147-152
109. MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3:354-361
110. Ertresvag JM, Zwart JA, Helde G, Johnsen HJ, Bovim G (2005) Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 111:233-237
111. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC (1993) Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33:385-389
112. Calton GJ, Burnett JW (1984) Danazol and migraine. N Engl J Med 310:721-722
113. Jonsson B, Von Reis G, Sahlgren E (1951) Testosterone therapy of headache. Acta Psychiatr Neurol Scand 74:102-105
114. Moehlig RC (1955) Methyl testosterone for migraine of women; report of sixty cases. J Mich State Med Soc 54:577-579
115. Vincent FM (1985) Migraine responsive to danazol. Neurology 35:618
116. Lichten EM, Bennett RS, Whitty AJ, Daoud Y (1991) Efficacy of danazol in the control of hormonal migraine. J Reprod Med 36(6):419-424
117. Arango O, Bielsa O, Pascual-Calvet J, Herrero M, Gelabert-Mas A (1996) Disappearance of migraine crises in two patients with male infertility treated with human chorionic gonadotropin/human menopausal gonadotrophin. Rev Neurol 24:977-979
118. Pringsheim T, Gooren L (2004) Migraine prevalence in male to female transsexuals on hormone therapy. Neurology 63:593-594
119. Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C (2009) Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119:99-109
120. Eikermann-Haerter K, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C (2009) Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol 66:564-568
121. Benarroch EE (2005) Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 80:1326-1338
122. Lian XY, Stringer JL (2004) Energy failure in astrocytes increases the vulnerability of neurons to spreading depression. Eur J Neurosci 19:2446-2454
123. Lian XY, Stringer JL (2007) Astrocytes contribute to regulation of extracellular calcium and potassium in the rat cerebral cortex during spreading depression. J Pharmacol Exp Ther 321:564-572
124. Giaume C, McCarthy KD (1996) Control of gap-junctional communication in astrocytic networks. Trends Neurosci 19:319-325
125. Bennett MVL, Contreras JE, Bukauskas FF, Sáez JC (2003) New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci 26:610-617
126. Nagy JI, Dudek FE, Rash JE (2004) Update on connexins and gap junctions in neurons and glia in the mammalian nervous system. Brain Res Rev 47:191-215
127. Ye Z-C, Wyeth MS, Baltan-Tekkok S, Ransom BR (2003) Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 23:3588-3596
128. Peters O, Schipke CG, Hashimoto Y, Kettenmann H (2003) Different mechanisms promote astrocyte Ca2+ waves and spreading depression in the mouse neocortex. J Neurosci 23(30):9888-9896
129. Stout CE, Costantin JL, Naus CCG, Charles AC (2002) Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277:10482-10488
130. Grafstein B, Liu S, Cotrina ML, Goldman SA, Nedergaard M (2000) Meningeal cells can communicate with astrocytes by calcium signaling. Ann Neurol 47:18-25
131. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447-1455
132. Martins-Oliveira A, Speciali JG, Dach F, Marcaccini AM, Gonçalves FM, Gerlach RF, Tanus-Santos JE (2009) Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408:60-64
133. Gao HM, Li L, Zhang KL, Chen XH, Tian SQ, Zhang ZL (2010) Impact of migraine attacks on the blood-brain barrier. Chin Med J (Engl) 123:2559-2561
134. Martins-Oliveira A, Gonçalves FM, Speciali JG, Fontana V, Izidoro-Toledo TC, Belo VA, Dach F, Tanus-Santos JE (2012) Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine. J Neuroimmunol 252:89-94
135. Gonçalves FM, Martins-Oliveira A, Lacchini R, Belo VA, Speciali JG, Dach F, Tanus-Santos JE (2013) Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura. Gene 512:35-40
136. Gupta VK (2009) CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother 9:1595-1614
137. Levy D (2012) Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression. Curr Pain Headache Rep 16:270-277
138. Lambert GA, Truong L, Zagami AS (2011) Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system. Cephalalgia 31(14):1439-1451
139. Ji R-R, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696-705
140. Goadsby PJ, Akerman S (2012) The trigeminovascular system does not require a peripheral sensory input to be activated-migraine is a central disorder. Focus on 'Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system'. Cephalalgia 32:3-5
141. Strassman AM, Raimond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headache. Nature 384:560-564
142. Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Koçak E, Sen ZD, Dalkara T (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092-1095
143. Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, Scemes E, Keane RW, Dahl G (2009) The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem 284:18143-18151
144. Müller S, Ronfani L, Bianchi ME (2004) Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 255:332-343
145. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A (2007) High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 103:590-603
146. Pontremoli S, Melloni E (2007) Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol 179:8525-8532
147. Read SJ, Parsons AA (2000) Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan? Brain Res 870:44-53
148. Read SJ, Hirst WD, Upton N, Parsons AA (2001) Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 891:69-77
149. Ayata C (2009) Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 29:1095-1114
150. Kaube H, Goadsby PJ (1994) Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol 34:30-35
151. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59:652-661
152. Unekawa M, Tomita Y, Toriumi H, Suzuki N (2012) Suppressive effect of chronic peroral topiramate on potassium-induced cortical spreading depression in rats. Cephalalgia 32:518-527
153. Akerman S, Goadsby PJ (2005) Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 16:1383-1387
154. Hoffmann U, Dileköz E, Kudo C, Ayata C (2010) Gabapentin suppresses cortical spreading depression susceptibility. J Cereb Blood Flow Metab 30:1588-1592
155. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19:64-66
156. Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura-a pilot study. Cephalalgia 19:58-63
157. Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730-1732
158. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109-112
159. Gupta P, Singh S, Goyal V, Shukla G, Behari M (2007) Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache 47:402-412
160. Bogdanov VB, Multon S, Chauvel V, Bogdanova OV, Prodanov D, Makarchuk MY, Schoenen J (2011) Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiol Dis 41:430-435
161. Marrannes R, Wauquier A, Reid K, De Prins E (1986) The Prelude to The Migraine Attack. Effects of drugs on cortical spreading depression. Baillière Tindal Oxford, UK, pp 158-173
162. Hansen A, Lauritzen M, Tfelt-Hansen P (1984) Spreading cortical depression and antimigraine drugs. In: Amery WK, Nueten JM, Waquier A (eds) The Pharmacological Basis of Migraine Therapy. Putman, London, UK, pp 161-170
163. Reid KH, Marrannes R, Wauquier A (1987) Effects of flunarizine on rat cerebral cortex. Drug Dev Res 10:107-116
164. Wauquier A, Ashton D, Marrannes R (1985) The effects of flunarizine in experimental models related to the pathogenesis of migraine. Cephalalgia 5 (2):119-123
165. Marrannes R, De Prins E, Fransen J, Clincke G (1993) Neuropharmacology of spreading depression. In: Lehmenkuhler A, Grotemeyer KH, Tegtmeier F (eds) Migraine: Basic Mechanisms and Treatment. MD, USA, Urban & Schwarzenberg, pp 431-443
166. Shimazawa M, Hara H, Watano T, Sukamoto T (1995) Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats. Br J Pharmacol 115:1359-1368
167. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V (1992) Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 12:21-27
168. Gallai V, Sarchielli P, Morucci P, Abbritti G (1994) Magnesium content of mononuclear blood cells in migraine patients. Headache 34:160-165
169. Gallai V, Sarchielli P, Morucci P, Abbritti G (1993) Red blood cell magnesium levels in migraine patients. Cephalalgia 13:94-101
170. Mauskop A, Altura BM (1998) Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 5:24-27
171. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM (1989) Low brain magnesium in migraine. Headache 29:590-593
172. Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22:345-353
173. van der Hel WS, van den Bergh WM, Nicolay K, Tulleken KA, Dijkhuizen RM (1998) Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport 9:2179-2182
174. Silberstein S, Saper J, Berenson F, Somogyi M, McCague K, D’Souza J (2008) Oxcarbazepine in migraine headache: a double-blind, randomized, placebocontrolled study. Neurology 70:548-555
175. Durham PL, Garrett FG (2009) Neurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine. Cephalalgia 29(Suppl 2):1-6
176. Silberstein SD, Schoenen J, Göbel H, Diener HC, Elkind AH, Klapper JA, Howard RA (2009) Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia 29(Suppl 2):17-27
177. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG (2009) Tonabersat TON-01-05 Study Group. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia 29:742-750
178. Dahlöf CG, Hauge AW, Olesen J (2009) Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia 29(Suppl 2):7-16
179. Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J (2009) Effects of tonabersat on migraine with aura: a randomised, double-blind, placebocontrolled crossover study. Lancet Neurol 8:718-723
180. Bradley DP, Smith MI, Netsiri C, Smith JM, Bockhorst KH, Hall LD, Huang CL, Leslie RA, Parsons AA, James MF (2001) Diffusion-Weighted MRI Used to Detect in Vivo Modulation of Cortical Spreading Depression: Comparison of Sumatriptan and Tonabersat. Exp Neurol 172:342-353
181. Damodaram S, Thalakoti S, Freeman SE, Garrett FG, Durham PL (2009) Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache 49:5-20
182. Holland PR, Akerman S, Andreou AP, Karsan N, Wemmie JA, Goadsby PJ (2012) Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol 72:559-563
183. Durham PL, Masterson CG (2013) Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment. Headache 53:67-80.
184. Yan J, Edelmayer RM, Wei X, De Felice M, Porreca F, Dussor G (2011) Dural afferents express acid-sensing ion channels: A role for decreased meningeal pH in migraine headache. Pain 152:106-113
185. Raddant AC, Russo AF (2011) Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med 13:e36
186. Seybold VS (2009) The role of peptides in central sensitization. Handb Exp Pharmacol 194:451-491
187. Wahl M, Schilling L, Parsons AA, Kaumann A (1994) Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 637:2004-2010
188. Colonna DM, Meng W, Deal DD, Busija DW (1994) Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am J Physiol 266:H1095-H1102
189. De Corato A, Lisi L, Capuano A, Tringali G, Tramutola A, Navarra P, Dello Russo C (2011) Trigeminal satellite cells express functional calcitonin generelated peptide receptors, whose activation enhances interleukin-1β proinflammatory effects. J Neuroimmunol 237:39-46
190. Piper RD P, Edvinsson L, Ekman R, Lambert GA (1993) Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia 13:180-183
191. Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179-1186
192. Negro A, Lionetto L, Simmaco M, Martelletti P (2012) CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs 21:807-818
193. Hoffmann J, Goadsby PJ (2012) New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors. Curr Treat Options Neurol 14:50-59
194. Diener HC, Barbanti P, Dahlöf C, Reuter U, Habeck J, Podhorna J (2011) BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. Cephalalgia 31:573-584
195. Chauvel V, Vamos E, Pardutz A, Vecsei L, Schoenen J, Multon S (2012) Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat. Exp Neurol 236:207-214
196. Hirota K, Sikand KS, Lambert DG (1999) Interaction of ketamine with mu2 opioid receptors in SH-SY5Y human neuroblastoma cells. J Anesth 13:107-109
197. Narita M, Yoshizawa K, Aoki K, Takagi M, Miyatake M, Suzuki T (2001) A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats. Addict Biol 6:373-376
198. Gorelova NA, Koroleva VI, Amemori T, Pavlík V, Burĕs J (1987) Ketamine blockade of cortical spreading depression in rats. Electroencephalogr Clin Neurophysiol 66:440-447
199. Rashidy-Pour A, Motaghed-Larijani Z, Bures J (1995) Tolerance to ketamineinduced blockade of cortical spreading depression transfers to MK-801 but not to AP5 in rats. Brain Res 693:64-69
200. Kaube H, Herzog J, Käufer T, Dichgans M, Diener HC (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55:139-141
201. Afridi SK, Giffin NJ, Kaube H, Goadsby PJ (2013) A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 80:642-647
202. Dhir A, Lossin C, Rogawski MA (2012) Propofol hemisuccinate suppresses cortical spreading depression. Neurosci Lett 514:67-70
203. Kudo C, Toyama M, Boku A, Hanamoto H, Morimoto Y, Sugimura M, Niwa H (2013) Anesthetic effects on susceptibility to cortical spreading depression. Neuropharmacol 67:32-36
204. Kudo C, Nozari A, Moskowitz MA, Ayata C (2008) The impact of anesthetics and hyperoxia on cortical spreading depression. Exp Neurol 212:201-206
205. Summ O, Holland PR, Akerman S, Goadsby PJ (2011) TRPV1 receptor blockade is ineffective in different in vivo models of migraine. Cephalalgia 31:172-180
206. Kazemi H, Rahgozar M, Speckmann EJ, Gorji A (2012) Effect of cannabinoid receptor activation on spreading depression. Iran J Basic Med Sci 15:926-936